Mekraldi Samia, Toromanoff Anne, Rizzoli René, Ammann Patrick
Service of Bone Diseases WHO Collaborating Center for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, University Hospital of Geneva, Geneva, Switzerland.
J Bone Miner Res. 2005 Aug;20(8):1365-71. doi: 10.1359/JBMR.050321. Epub 2005 Mar 21.
Isocaloric dietary protein deficiency is associated with decreased BMD and bone strength as well as depressed somatotroph and gonadotroph axis. Inhibition of increased bone resorption by the bisphosphonate pamidronate in rats fed an isocaloric low-protein diet fully prevents bone loss and alteration of bone strength.
Isocaloric dietary protein deficiency is associated with decreased BMD and bone strength as well as depressed somatotroph and gonadotroph axis. This negative bone balance is the consequence of increased bone resorption and decreased bone formation. Whether inhibition of bone resorption could prevent low-protein diet-induced bone loss and alteration of biomechanics is not known.
The effect of the bisphosphonate pamidronate was studied in 5.5-month-old female or 6-month-old male rats pair-fed a control (15% casein) or an isocaloric low-protein (2.5% casein) diet for 19 and 26 weeks, respectively. Pamidronate (0.6 mg/kg) was given subcutaneously 5 days/month for 4 months in female rats or for 5 months in male rats. BMD, microarchitecture, and bone strength were measured at the level of the proximal and midshaft tibia. Urinary deoxypyridinoline excretion, serum osteocalcin, and IGF-I were also measured.
The increase in bone resorption in female rats (+100%) and in male rats (+33%) fed a low-protein diet was prevented by pamidronate treatment. The reduced osteocalcin levels observed in rats fed a low-protein diet were further decreased in both female (-34%) and male (-30%) rats treated with pamidronate. The bone turnover decrease induced by pamidronate prevented bone strength reduction, trabecular bone loss, microarchitecture, and BMD alterations induced by the isocaloric low-protein diet. Similar effects were observed at the level of the midshaft tibia. Significant decrease of plasma IGF-I was observed in rats fed a low-protein diet independently of the pamidronate treatment.
In conclusion, inhibition of increased bone resorption in rats fed an isocaloric low-protein diet fully prevents bone loss and alteration of bone strength.
等热量饮食蛋白质缺乏与骨密度和骨强度降低以及生长激素和促性腺激素轴受抑制有关。在喂食等热量低蛋白饮食的大鼠中,双膦酸盐帕米膦酸盐抑制骨吸收增加可完全预防骨质流失和骨强度改变。
等热量饮食蛋白质缺乏与骨密度和骨强度降低以及生长激素和促性腺激素轴受抑制有关。这种负性骨平衡是骨吸收增加和骨形成减少的结果。抑制骨吸收是否能预防低蛋白饮食诱导的骨质流失和生物力学改变尚不清楚。
在5.5月龄雌性或6月龄雄性大鼠中研究双膦酸盐帕米膦酸盐的作用,分别对其成对喂食对照(15%酪蛋白)或等热量低蛋白(2.5%酪蛋白)饮食19周和26周。雌性大鼠皮下注射帕米膦酸盐(0.6mg/kg),每月5天,持续4个月;雄性大鼠持续5个月。在胫骨干近端和中段测量骨密度、微观结构和骨强度。还测量了尿脱氧吡啶啉排泄、血清骨钙素和胰岛素样生长因子-I。
帕米膦酸盐治疗可预防喂食低蛋白饮食的雌性大鼠(增加100%)和雄性大鼠(增加33%)骨吸收增加。在喂食低蛋白饮食的大鼠中观察到的骨钙素水平降低,在用帕米膦酸盐治疗的雌性(降低34%)和雄性(降低30%)大鼠中进一步降低。帕米膦酸盐诱导的骨转换降低可预防等热量低蛋白饮食诱导的骨强度降低、小梁骨丢失、微观结构和骨密度改变。在胫骨干中段也观察到类似效果。在喂食低蛋白饮食的大鼠中,无论是否进行帕米膦酸盐治疗,均观察到血浆胰岛素样生长因子-I显著降低。
总之,在喂食等热量低蛋白饮食的大鼠中,抑制增加的骨吸收可完全预防骨质流失和骨强度改变。